- Home
- ACXP vs SUGP Comparison
ACXP vs SUGP Comparison
Compare ACXP & SUGP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACXP
- SUGP
- Stock Information
- Founded
- ACXP 2017
- SUGP 1998
- Country
- ACXP United States
- SUGP Hong Kong
- Employees
- ACXP N/A
- SUGP N/A
- Industry
- ACXP Biotechnology: Pharmaceutical Preparations
- SUGP
- Sector
- ACXP Health Care
- SUGP
- Exchange
- ACXP Nasdaq
- SUGP NYSE
- Market Cap
- ACXP 32.0M
- SUGP 22.8M
- IPO Year
- ACXP 2021
- SUGP 2024
- Fundamental
- Price
- ACXP $1.96
- SUGP $1.17
- Analyst Decision
- ACXP Strong Buy
- SUGP
- Analyst Count
- ACXP 1
- SUGP 0
- Target Price
- ACXP $12.00
- SUGP N/A
- AVG Volume (30 Days)
- ACXP 40.2K
- SUGP 75.9K
- Earning Date
- ACXP 11-13-2024
- SUGP 11-02-2024
- Dividend Yield
- ACXP N/A
- SUGP N/A
- EPS Growth
- ACXP N/A
- SUGP N/A
- EPS
- ACXP N/A
- SUGP 0.10
- Revenue
- ACXP N/A
- SUGP $20,252,232.00
- Revenue This Year
- ACXP N/A
- SUGP N/A
- Revenue Next Year
- ACXP N/A
- SUGP N/A
- P/E Ratio
- ACXP N/A
- SUGP $11.89
- Revenue Growth
- ACXP N/A
- SUGP N/A
- 52 Week Low
- ACXP $1.52
- SUGP $0.98
- 52 Week High
- ACXP $5.70
- SUGP $5.86
- Technical
- Relative Strength Index (RSI)
- ACXP 42.21
- SUGP 42.50
- Support Level
- ACXP $1.99
- SUGP $1.14
- Resistance Level
- ACXP $2.14
- SUGP $1.25
- Average True Range (ATR)
- ACXP 0.10
- SUGP 0.12
- MACD
- ACXP -0.01
- SUGP 0.02
- Stochastic Oscillator
- ACXP 22.58
- SUGP 22.97
About ACXP Acurx Pharmaceuticals Inc.
Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration.
About SUGP SU GROUP HLDGS LTD
SU Group Holdings Ltd and its subsidiaries is an integrated security-related services company. The company has two reportable segments: security-related engineering services, and security guarding and screening services and related vocational training services. The company generates the majority of its revenue from the security-related engineering services segment.